Humoral injury in porcine livers perfused with human whole blood

Transplantation

Volumn 64, Issue 8, 1997, Pages 1117-1123

  Satoh, Seiji ^a   Terajima, Hiroaki ^a   Yagi, Toshikazu ^a   Kanazawa, Akiyoshi ^a   Shinohara, Hisashi ^a   Gomi, Takashi ^a   Uesugi, Takehiko ^a   Yoneyama, Tetsuji ^a   Ikai, Iwao ^a   Takahashi, Rei ^a   Yamamoto, Masayuki ^a   Yamaoka, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN M; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; DISEASE SEVERITY; ENZYME RELEASE; HEMOGLOBIN ANALYSIS; HISTOPATHOLOGY; LIVER INJURY; LIVER PERFUSION; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BILE; COMPLEMENT MEMBRANE ATTACK COMPLEX; EXTRACORPOREAL CIRCULATION; HEMODYNAMIC PROCESSES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TRANSPLANTATION; RECEPTORS, COMPLEMENT; REPERFUSION INJURY; SWINE; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030671177     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199710270-00006     Document Type: Article

References (30)

1. Platt JL. A perspective on xenograft rejection and accommodation. Immunol Rev 1994; 141: 127.
2. Auchincloss H Jr. Xenogeneic transplantation. Transplantation 1988; 46: 1.
3. Collins BH, Chari RS, Magee JC, et al. Mechanism of injury in porcine livers perfused with blood of patients with fulminant hepatic failure. Transplantation 1994; 58: 1162.
4. Sandrin MS, McKenzie IFC. Ga1α(1,3)Gal: the major xenoantigen(s), recognized in pigs by human natural antibodies. Immunol Rev 1994; 141: 169.
5. Yagi T, Terajima H, Mashima S, et al. Discordant effects of xenogeneic pig liver perfusion on function of sinusoidal endothelial cells and parenchymal cells. Transplant Proc 1996; 28: 1402.
6. Terajima H, Shirakata Y, Yagi T, et al. Successful long term xenoperfusion of the pig liver: continuous administration of prostaglandin E and insulin. Transplantation 1997; 63(4): 507.
7. Vaubourdolle M, Chazouilleres O, Poupon R. Creatine kinase-BB: a marker of liver sinusoidal damage in ischemia-reperfusion. Hepatology 1993; 17: 423.
8. Karayalcin K, Harrison JD, Attard A. Can effluent hyaluronic acid or creatine kinase predict sinusoidal injury severity after cold ischemia? Transplantation 1993; 56: 1336.
9. Hsu S, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 1981; 29: 577.
10. Shinohara H, Tanaka A, Kitai T, et al. Direct measurement of hepatic indocyanine green clearance with near-infrared spectroscopy: separate evaluation of uptake and removal. Hepatology 1996; 23: 137.
11. Chari RS, Collins BH, Magee JC, et al. Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med 1994; 331: 234.
12. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363.
13. Rosengard AM, Cary NRB, Langford GA, Tucker AW, Wallwork J, White DJG. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. Transplantation 1995; 59: 1325.
14. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1: 423.
15. Homeister JW, Satoh PS, Kilgore KS, Lucchesi BR. Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. J Immunol 1993; 150: 1055.
16. Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249: 146.
17. Danielsson C, Pascual M, French L, Steiger G, Shifferli JA. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur J Immonol 1994; 24: 2725.
18. Miyagawa S, Shirakura R, Matsumiya G. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation. Transplant Proc 1994; 26: 1235.
19. Takahashi M, Ishikura H, Takahashi C, Nakajima, Uchino J, Yoshiki T. Immunologic consideration in the use of cultured porcine hepatocytes as a hybrid artificial liver. ASAIO J 1993; 39: M242.
20. Maggiono N, Citterio F, Evangelista A, Pozzetto U, Castangneto M, Capelli A. Immunomicroscopical localization of human preformed natural antibodies against pig tissues in xenogeneic transplantation. Histochem J 1994; 26: 553.
21. Saadi S, Ihrcke NS, Platt JL. Endothelial cell shape and hyperacute rejection. Transplat Proc 1994; 26: 1149.
22. Lenzi R, Alpini G, Lui MH, Rand JH, Tavoloni N. von Willebrand factor antigen is not an accurate marker of rat and guinea pig liver endothelial cells. Liver 1990; 10: 372.
23. Knittel T, Neubauer K, Aumbrust T, Ramadori G. Expression of von Willebrand factor in normal and diseased rat livers and in cultivated liver cells. Hepatology 1995; 21: 470.
24. Holzknecht ZE, Platt JL. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive natural antibodies. J Immunol 1995; 154: 4565.
25. Cheung AK, Parker CJ, Hohnholt M. Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membrane in vitro. Kidney Int 1994; 46: 1680.
26. Henderson LW, Chenoweth D. Biocompatibility of artificial organs: an overview. Blood Purif 1987; 5: 100.
27. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol 1993; 264: G801.
28. Zehr KJ, Herskowitz A, Lee PC, Kumar P, Gillnov AM, Baumgartner WA. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 1994; 57: 900.
29. Mulligan MS, Yeh CG, Rudolph AR, Ward PA. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. J Immunol 1992; 148: 1479.
30. Swift AJ, Collins TS, Bugelski P, Winkelstein JA. Soluble human complement receptor type 1 inhibits complement-mediated host defense. Clin Diagnost Lab Immunol 1994; 1: 585.